PortfoliosLab logoPortfoliosLab logo
ARTV vs. PSTV
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

ARTV vs. PSTV - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Artiva Biotherapeutics, Inc (ARTV) and Plus Therapeutics Inc (PSTV). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, ARTV achieves a 135.43% return, which is significantly higher than PSTV's -69.78% return.


ARTV

1D
-3.16%
1M
5.10%
6M
159.64%
YTD
135.43%
1Y
256.89%
3Y*
5Y*
10Y*
ALL TIME*
-20.26%

PSTV

1D
6.03%
1M
-2.76%
6M
-32.14%
YTD
-69.78%
1Y
-73.54%
3Y*
-60.44%
5Y*
-64.76%
10Y*
-68.48%
ALL TIME*
-46.26%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Liquidity Comparison


PositionAvg. Volume Value (2W)Avg. Volume Value (1M)Avg. Volume Value (3M)
$3.62M$4.01M$5.66M
$257.63K$483.90K$790.28K

ARTV vs. PSTV - Yearly Performance Comparison


2026 (YTD)20252024
ARTV
Artiva Biotherapeutics, Inc
135.43%-57.44%-37.00%
PSTV
Plus Therapeutics Inc
-69.78%-55.45%-33.53%

Correlation

The correlation between ARTV and PSTV is 0.15, which is low. Their historical price movements had little consistent relationship.


Correlation
Correlation (1Y)
Focuses on recent behavior, but can change the most.

0.15

Correlation (All Time)
Calculated using the full available price history since Jul 19, 2024

0.20

Fundamentals

Market Cap

ARTV:

$249.64M

PSTV:

$9.36M

EPS

ARTV:

-$3.55

PSTV:

-$3.65

PB Ratio

ARTV:

2.84

PSTV:

2.15

Total Revenue (TTM)

ARTV:

$0.00

PSTV:

$4.15M

Gross Profit (TTM)

ARTV:

$0.00

PSTV:

$3.89M

EBITDA (TTM)

ARTV:

-$90.10M

PSTV:

-$1.39M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Artiva Biotherapeutics, Inc

Plus Therapeutics Inc

Often compared with ARTV:
ARTV vs. CGON
Often compared with PSTV:
PSTV vs. TNYAPSTV vs. ARCC

Return for Risk

ARTV vs. PSTV — Risk / Return Rank

Compare historical risk-adjusted metric ranks over the past 12 months.

ARTV
ARTV Risk / Return Rank: 9090
Overall Rank
ARTV Sharpe Ratio Rank: 8181
Sharpe Ratio Rank
ARTV Sortino Ratio Rank: 9595
Sortino Ratio Rank
ARTV Omega Ratio Rank: 9191
Omega Ratio Rank
ARTV Calmar Ratio Rank: 9595
Calmar Ratio Rank
ARTV Martin Ratio Rank: 8888
Martin Ratio Rank

PSTV
PSTV Risk / Return Rank: 1919
Overall Rank
PSTV Sharpe Ratio Rank: 1919
Sharpe Ratio Rank
PSTV Sortino Ratio Rank: 2222
Sortino Ratio Rank
PSTV Omega Ratio Rank: 2323
Omega Ratio Rank
PSTV Calmar Ratio Rank: 1313
Calmar Ratio Rank
PSTV Martin Ratio Rank: 1818
Martin Ratio Rank
The rank (0–100) uses a weighted average of the Sharpe, Sortino, Omega, Calmar, and Martin percentile ranks for the trailing 12 months. Higher means stronger historical risk-adjusted performance within the peer group.

ARTV vs. PSTV - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Artiva Biotherapeutics, Inc (ARTV) and Plus Therapeutics Inc (PSTV). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


ARTVPSTVDifference
Sharpe ratioReturn per unit of total volatility

+1.83

Sortino ratioReturn per unit of downside risk

+3.82

Omega ratioGain probability vs. loss probability

1.39

0.95

+0.44

Calmar ratioReturn relative to maximum drawdown

4.84

-0.78

+5.63

Martin ratioReturn relative to average drawdown

8.47

-1.14

+9.61

ARTV vs. PSTV - Sharpe Ratio Comparison

The current ARTV Sharpe Ratio is 1.29, which is higher than the PSTV Sharpe Ratio of -0.55. The chart below compares the historical Sharpe Ratios of ARTV and PSTV, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

ARTV vs. PSTV - Drawdown Comparison

The maximum ARTV drawdown since its inception was -90.81%, smaller than the maximum PSTV drawdown of -100.00%. Use the drawdown chart below to compare losses from any high point for ARTV and PSTV.


Loading charts...

Drawdown Indicators


ARTVPSTVDifference

Max Drawdown

Largest peak-to-trough decline

-90.81%

-100.00%

+9.19%

Max Drawdown (1Y)

Largest decline over 1 year

-49.22%

-86.87%

+37.65%

Max Drawdown (3Y)

Largest decline over 3 years

-96.30%

Max Drawdown (5Y)

Largest decline over 5 years

-99.64%

Max Drawdown (10Y)

Largest decline over 10 years

-100.00%

Current Drawdown

Current decline from peak

-36.87%

-100.00%

+63.13%

Average Drawdown

Average peak-to-trough decline

-59.47%

-79.61%

+20.14%

Ulcer Index

Depth and duration of drawdowns from previous peaks

28.08%

59.76%

-31.68%

Volatility

ARTV vs. PSTV - Volatility Comparison

Artiva Biotherapeutics, Inc (ARTV) has a higher volatility of 22.04% compared to Plus Therapeutics Inc (PSTV) at 15.15%. This indicates that ARTV's price experiences larger fluctuations and is considered to be riskier than PSTV based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


ARTVPSTVDifference

Volatility (1M)

Calculated over the trailing 1-month period

22.04%

15.15%

+6.89%

Volatility (6M)

Calculated over the trailing 6-month period

76.82%

70.71%

+6.11%

Volatility (1Y)

Calculated over the trailing 1-year period

185.35%

124.68%

+60.67%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

155.78%

198.03%

-42.25%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

155.78%

184.29%

-28.51%

Dividends

ARTV vs. PSTV - Dividend Comparison

Neither ARTV nor PSTV has paid dividends to shareholders.


Tickers have no history of dividend payments

Financials

ARTV vs. PSTV - Financials Comparison

This section allows you to compare key financial metrics between Artiva Biotherapeutics, Inc and Plus Therapeutics Inc. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items

Frequently Asked Questions


ARTV and PSTV have a correlation of 0.15, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

ARTV has higher volatility (22.04%) compared to PSTV (15.15%). In terms of maximum drawdown, ARTV dropped -90.81% vs PSTV's -100.00%.

ARTV currently has the higher Sharpe Ratio (1.29 vs -0.55), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for ARTV and PSTV

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer